Palvella Therapeutics, Inc. (PVLA) earnings
PVLA earnings moved a median of +2.84% by the close. Quarterly and annual PVLA reports and results, each read against the price at its own news timestamp. Back to the PVLA overview →
14 measured PVLA earnings events.
Where these PVLA earnings landedvs 14 measured PVLA earnings reactions
| Middle 50% of PVLA earnings reactions | -0.04% to +4.96% |
|---|---|
| Median reaction (to close) | +2.84% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 PVLA earnings events with a measured close landed between -0.04% and +4.96%; 71% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PALVELLA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +4.97% | +12.34% | |
| Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +4.97% | +12.34% | |
| Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026 | Press release | +0.45% | +0.39% | |
| Form 10-Q PALVELLA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -7.33% | -12.24% | |
| Palvella Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -7.33% | -12.24% | |
| Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026 | Press release | +0.00% | +3.21% | |
| Form 10-K PALVELLA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -4.79% | +7.85% | |
| Form 10-Q PALVELLA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.89% | +3.50% | |
| Palvella Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +4.51% | +2.29% | |
| Palvella Therapeutics to Host Third Quarter 2025 Financial Results and Corporate Update Conference Call on November 11, 2025 | Press release | +1.24% | -0.34% | |
| Palvella Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +3.06% | +5.18% | |
| Palvella Therapeutics to Host Second Quarter 2025 Financial Results and Corporate Update Conference Call on August 14, 2025 | Press release | +0.00% | -0.18% | |
| Palvella Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.00% | +2.47% | |
| Palvella Therapeutics to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025 | Press release | +0.00% | +4.30% |
Keep exploring
More PVLA: analyst actions → · SEC filings → · PVLA overview →